Houston's World Cup security lockdown is underway, but a $110 million immigration funding dispute could threaten emergency response, heat safety, and medical preparedness plans.

A new study found that intermittent fasting doesn't just change your waistline — it changes your gut bacteria and the structure of your brain's cravings circuitry simultaneously.

Researchers at Karolinska Institutet published a study showing a new oral compound activates muscle metabolism to lower blood sugar and torch fat — without nausea, muscle loss, or the side effects plaguing GLP-1 drugs.

A Harvard-affiliated research team used artificial intelligence to analyze CT scans from tens of thousands of Americans — and discovered that a small organ most doctors ignored after your teens could predict when you'll die.

Drugs like Ozempic and Wegovy — already reshaping obesity treatment — may also slash overdose deaths, ER visits, and alcohol dependence, according to the largest study ever conducted on GLP-1s and addiction.

A new oral drug called daraxonrasib stunned researchers at this year's ASCO conference in Chicago, slashing the risk of death from metastatic pancreatic cancer by 60%.

A novel PET radiotracer can accurately detect deep vein thrombosis in the legs and reveal whether clots have migrated to the lungs. By enabling whole-body imaging of blood clots in a single scan, the approach may support faster and more efficient diagnosis—particularly for patients who also require evaluation for potentially life-threatening pulmonary embolism. This research was presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2026 Annual Meeting, and the collection of images showcasing the visualization of blood clots in the legs and in the lungs has been selected as the 2026 SNMMI Henry N. Wagner, Jr., Image of the Year.

Infections should be considered a "health hazard" in people living with diabetes, with experts warning that current clinical guidelines fail to reflect a substantial but underrecognized burden of illness, hospitalization and death. This is according to a major study published today in Diabetes and presented at the American Diabetes Association Scientific Sessions conference in New Orleans.

For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic cancer between 2015 and 2021, about 97% died within five years of their diagnosis.

A research team has developed technology that uses artificial intelligence to analyze electroencephalogram signals triggered by thermal stimuli and objectively classify pain intensity. The study is published in IEEE Transactions on Neural Systems and Rehabilitation Engineering.